No Data
Strong Biopharma Dealmaking Market Set to Continue
Piper Sandler Maintains Overweight on Amgen, Lowers Price Target to $427
Trump 'Most Favored Nation' Drug Policy Risks China R&D Takeover
Pharmaceutical Drug Delivery Market Worth $2,922.82 Billion by 2031 | MarketsandMarkets
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $427
Piper Sandler Adjusts Price Target on Amgen to $427 From $432, Maintains Overweight Rating
WH565 : Barking up the wrong tree
包爷 : cargill already cause fertz and grains futures plunge this morning alongside freight rates, although it rebounded now. all eyes on soybeans and beef tomorrow